It has been shown that rapamycin and other mTOR inhibitors attenuate T cell migration and development of neuroinflammation which trigger epilepsy and SE in different autoimmune disorders like new-onset refractory SE and encephalitis-induced seizure (Shimada et al. 2013; Crino 2019). The gene discussed is MTOR; the disease is epilepsy.